What is the global market size of Consumer Healthcare Market?

Consumer Healthcare Market size was valued at USD 339.22 billion in 2021 and is poised to grow from USD 364.41 billion in 2022 to USD 646.65 billion by 2030, growing at a CAGR of 7.43% in the forecast period (2023-2030).

Who are the key vendors in the Global Consumer Healthcare Market?

In terms of revenue, GSK is dominating the global consumer healthcare market. Wherein, the oral health and pain relief segment is dominating the market and is expected to do so in the coming years. On the other hand, J&J invested the hefty sum in the consumer healthcare segment between the years 2016 and 2020 followed by Pfizer and GSK to attain large market share and tap the lucrative growth opportunity, especially in developing market like India and China. 'Johnson & Johnson', 'Procter & Gamble', 'GlaxoSmithKline plc', 'Pfizer Inc.', 'Novartis International AG', 'Sanofi', 'Bayer AG', 'Reckitt Benckiser Group plc', 'Abbott Laboratories', 'Merck & Co., Inc.', 'Nestlé S.A.', 'Colgate-Palmolive Company', 'Boehringer Ingelheim GmbH', 'Bristol-Myers Squibb Company', 'Eli Lilly and Company', 'Teva Pharmaceutical Industries Ltd.', 'Mylan N.V.', 'Perrigo Company plc', 'Allergan plc', 'GlaxoSmithKline Consumer Healthcare.', 'In February 2022, GlaxoSmithKline plc (GSK) revealed the name of the new business that would emerge from GSK's proposed demerger of Consumer Healthcare in mid-2022, Haleon.', 'In February 2022, Ipsen engaged in a divestment agreement with Mayoly Spindler, a French pharmaceutical company, in which Ipsen decided to sell its global consumer health portfolio.', 'In January 2022, GSK, one of the key players in the global consumer healthcare market, strategized to sell its consumer health unit to Unilever and Pfizer as consumer health joint venture. However, Unilever will not increase its bid for the GSK-Pfizer consumer health joint venture above 50 billion pounds (USD 68 billion). With Unilever's exit, GSK is back to its original goal for a spinoff by mid-2022.'

What is the key driver of Global Consumer Healthcare Market?

Easy Availability and High Awareness Among Consumers Driving Growth of Consumer Healthcare Market

What is the key market trend for Global Consumer Healthcare Market?

People all across the world are becoming more health-conscious and aware of the influence of individual lifestyle choices on their own and others' health. This rising understanding has the potential to change the way we think about health care, causing us to become our own health advocates, exploring strategies to enhance and preserve our own health. This global trend of health ownership is predicted to stimulate growth of the consumer healthcare market on a variety of fronts. Furthermore, self-care can help alleviate the increasing resource strain on healthcare systems and governments.

Which region accounted for the largest share in Global Consumer Healthcare Market?

The Asia Pacific consumer healthcare market is projected to continue witnessing the fastest growth during the forecast period by the virtue of shift in consumer attitudes toward self-medication, an increase in the elderly population, a quick move from Rx to OTC, and the affordability of OTC medications. Europe is estimated to be the second-largest market during the forecast period due to the increasing acceptance of self-medication and the existence of a significant number of OTC medicine manufacturing firms in this region. In addition, increased public awareness of OTC products is propelling the expansion of consumer healthcare market in the region.

Top Consumer Healthcare Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Consumer Healthcare Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Consumer Healthcare industry players.

Consumer Healthcare Market Competitive Landscape

In terms of revenue, GSK is dominating the global consumer healthcare market. Wherein, the oral health and pain relief segment is dominating the market and is expected to do so in the coming years. On the other hand, J&J invested the hefty sum in the consumer healthcare segment between the years 2016 and 2020 followed by Pfizer and GSK to attain large market share and tap the lucrative growth opportunity, especially in developing market like India and China.

Consumer Healthcare Market Top Players Company Profiles

Johnson & Johnson
Procter & Gamble
GlaxoSmithKline plc
Pfizer Inc.
Novartis International AG
Sanofi
Bayer AG
Reckitt Benckiser Group plc
Abbott Laboratories
Merck & Co., Inc.
Nestlé S.A.
Colgate-Palmolive Company
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Perrigo Company plc
Allergan plc
GlaxoSmithKline Consumer Healthcare.

Recent Developments in Global Consumer Healthcare Market

In February 2022, GlaxoSmithKline plc (GSK) revealed the name of the new business that would emerge from GSK's proposed demerger of Consumer Healthcare in mid-2022, Haleon.
In February 2022, Ipsen engaged in a divestment agreement with Mayoly Spindler, a French pharmaceutical company, in which Ipsen decided to sell its global consumer health portfolio.
In January 2022, GSK, one of the key players in the global consumer healthcare market, strategized to sell its consumer health unit to Unilever and Pfizer as consumer health joint venture. However, Unilever will not increase its bid for the GSK-Pfizer consumer health joint venture above 50 billion pounds (USD 68 billion). With Unilever's exit, GSK is back to its original goal for a spinoff by mid-2022.

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Global Consumer Healthcare Market size was valued at USD 302.36 Billion in 2024 and is poised to grow from USD 325.34 Billion in 2025 to USD 584.57 Billion by 2033, growing at a CAGR of 7.6% during the forecast period (2026–2033).

The state of competition in the global consumer healthcare market involves both the presence of well-established global companies as well as new entrants with promising product innovations. Henry Schein, Inc., Procter & Gamble, GlaxoSmithKline and Bayer are some of the prominent players commanding the market by virtue of strong research and development, wide distribution, and effective promotion. In addition, increasing consumer propensity towards natural & organic products has opened doors for niche brand competition which in turn increases innovation and the range of available products within the industry. 'Haleon plc (United Kingdom)', 'Kenvue Inc. (USA) ', 'McKesson Corporation (USA) ', 'Sun Pharmaceutical Industries Limited (India) ', 'Zydus Wellness Limited (India) ', 'Procter & Gamble Co. (USA) ', 'Unilever plc (United Kingdom/Netherlands) ', 'Nestlé Health Science (Switzerland) ', 'Reckitt Benckiser Group plc (United Kingdom) ', 'Sanofi Consumer Healthcare (France) ', 'Bayer Consumer Health (Germany) ', 'Pfizer Consumer Healthcare (USA) ', 'Johnson & Johnson Consumer Inc. (USA) ', 'Abbott Laboratories (USA) ', 'GlaxoSmithKline Consumer Healthcare (United Kingdom) ', 'Amway Corporation (USA) ', 'Herbalife Nutrition Ltd. (USA) ', 'Nature's Bounty Co. (USA)'

The improvement of consumer attitude regarding health and wellness is among the factors responsible for the growth of the global consumer healthcare market. As people understand more about preventive health care and self-care, they begin to reach out for non-prescription medicines and nutritional health products which in turn facilitates the expansion of the market and the rise in the variety of products sold in the market.

Growing Demand for Personalization: There is a growing trend within the global consumer healthcare market in favor of health offerings that are based on the specific needs and diversity of everyone. Organizations are capitalizing on data analytics combined with technology to come up with specific heath regimens, targeted food supplements among other services that focus on addressing specific health needs making clients happy and loyal from within.

North America consumer healthcare market share dominates due to its advanced healthcare infrastructure, high disposable income, and increasing consumer awareness of health and wellness. The region enjoys a fully functioning system of retail and online distribution channels enabling accessibility to a variety of healthcare products. Moreover, safety and efficacy concerns about the products are addressed by the existing legal structures, thus promoting trust amongst consumers. With the rising risk factors of the population leading to improvements in self-medication and preventive health care coupled with effective marketing campaigns by the major players, the North American market continues to grow thus maintaining its dominance in the global consumer healthcare market growth.

Top Consumer Healthcare Companies

Consumer Healthcare Market Competitive Landscape

FAQs

What is the global market size of Consumer Healthcare Market?

Who are the key vendors in the Consumer Healthcare Market?

What is the key driver of Consumer Healthcare Market?

What is the key market trend for Consumer Healthcare Market?

Which region accounted for the largest share in Consumer Healthcare Market?

Request Free Customization